Cargando…
Management of Elderly Asthma: Key Questions and Tentative Answers
The aging lung undergoes structural changes, immunosenescence, and inflammation, rendering the elderly more susceptible to developing obstructive airway disease. Thus, asthma in those of chronological age ≥ 65 years is not rare. Elderly asthma (EA) imposes considerable burdens in terms of mortality...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880298/ https://www.ncbi.nlm.nih.gov/pubmed/36693354 http://dx.doi.org/10.4168/aair.2023.15.1.8 |
_version_ | 1784878877047259136 |
---|---|
author | Park, Heung-Woo Cho, Sang Heon |
author_facet | Park, Heung-Woo Cho, Sang Heon |
author_sort | Park, Heung-Woo |
collection | PubMed |
description | The aging lung undergoes structural changes, immunosenescence, and inflammation, rendering the elderly more susceptible to developing obstructive airway disease. Thus, asthma in those of chronological age ≥ 65 years is not rare. Elderly asthma (EA) imposes considerable burdens in terms of mortality and morbidity, and expenditure. However, clinicians lack knowledge of EA and thus often prescribe inappropriate management. In this review, we ask 3 key questions frequently encountered during EA diagnosis and treatment: 1) Is EA different?; 2) How can we appropriately diagnose EA?; 3) Are there management strategies specific to EA? Based on recent studies, we provide tentative answers as follows: 1) late-onset EA differs in clinical features and pathogenetic mechanisms from non-EA, and thus further phenotypic and endotypic characterization of EA is needed; 2) both over- and under-diagnosis of asthma in the elderly can be reduced if the objective diagnostic tests are appropriately performed; 3) cautious prescription of ICS to selected EA patients should be encouraged, and a multifaceted approach which involves increasing medical awareness and inhaler use proficiency and adherence, seeking the assistance of caregivers, and correcting micronutrient deficiencies is required to reduce acute exacerbations in EA patients. |
format | Online Article Text |
id | pubmed-9880298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease |
record_format | MEDLINE/PubMed |
spelling | pubmed-98802982023-02-07 Management of Elderly Asthma: Key Questions and Tentative Answers Park, Heung-Woo Cho, Sang Heon Allergy Asthma Immunol Res Review The aging lung undergoes structural changes, immunosenescence, and inflammation, rendering the elderly more susceptible to developing obstructive airway disease. Thus, asthma in those of chronological age ≥ 65 years is not rare. Elderly asthma (EA) imposes considerable burdens in terms of mortality and morbidity, and expenditure. However, clinicians lack knowledge of EA and thus often prescribe inappropriate management. In this review, we ask 3 key questions frequently encountered during EA diagnosis and treatment: 1) Is EA different?; 2) How can we appropriately diagnose EA?; 3) Are there management strategies specific to EA? Based on recent studies, we provide tentative answers as follows: 1) late-onset EA differs in clinical features and pathogenetic mechanisms from non-EA, and thus further phenotypic and endotypic characterization of EA is needed; 2) both over- and under-diagnosis of asthma in the elderly can be reduced if the objective diagnostic tests are appropriately performed; 3) cautious prescription of ICS to selected EA patients should be encouraged, and a multifaceted approach which involves increasing medical awareness and inhaler use proficiency and adherence, seeking the assistance of caregivers, and correcting micronutrient deficiencies is required to reduce acute exacerbations in EA patients. The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2023-01-09 /pmc/articles/PMC9880298/ /pubmed/36693354 http://dx.doi.org/10.4168/aair.2023.15.1.8 Text en Copyright © 2023 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Park, Heung-Woo Cho, Sang Heon Management of Elderly Asthma: Key Questions and Tentative Answers |
title | Management of Elderly Asthma: Key Questions and Tentative Answers |
title_full | Management of Elderly Asthma: Key Questions and Tentative Answers |
title_fullStr | Management of Elderly Asthma: Key Questions and Tentative Answers |
title_full_unstemmed | Management of Elderly Asthma: Key Questions and Tentative Answers |
title_short | Management of Elderly Asthma: Key Questions and Tentative Answers |
title_sort | management of elderly asthma: key questions and tentative answers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880298/ https://www.ncbi.nlm.nih.gov/pubmed/36693354 http://dx.doi.org/10.4168/aair.2023.15.1.8 |
work_keys_str_mv | AT parkheungwoo managementofelderlyasthmakeyquestionsandtentativeanswers AT chosangheon managementofelderlyasthmakeyquestionsandtentativeanswers |